Stryker Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
January 27, 2021 at 04:05 pm EST
Share
Stryker Corporation announced earnings results for the fourth quarter ended December 31, 2020. For the fourth quarter, the company announced sales was USD 4,262 million compared to USD 4,131 million a year ago. Operating income was USD 749 million compared to USD 944 million a year ago. Net income was USD 568 million compared to USD 725 million a year ago. Basic earnings per share from continuing operations was USD 1.51 compared to USD 1.94 a year ago. Diluted earnings per share from continuing operations was USD 1.49 compared to USD 1.9 a year ago. For the full year, sales was USD 14,351 million compared to USD 14,884 million a year ago. Operating income was USD 2,223 million compared to USD 2,713 million a year ago. Net income was USD 1,599 million compared to USD 2,083 million a year ago. Basic earnings per share from continuing operations was USD 4.26 compared to USD 5.57 a year ago. Diluted earnings per share from continuing operations was USD 4.2 compared to USD 5.48 a year ago.
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows:
- surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment;
- orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants.
At the end of 2022, the group had 48 production sites worldwide.
Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
STRYKER CORPORATION 
